Effectiveness and Safety/Tolerability of Eslicarbazepine Acetate in Epilepsy Patients Aged ≥ 60 Versus < 60 Years: A Subanalysis from the Euro-Esli Study
Crossref DOI link: https://doi.org/10.1007/s40120-019-0137-0
Published Online: 2019-05-16
Published Print: 2019-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lawthom, Charlotte http://orcid.org/0000-0003-1774-6506
Bermejo, Pedro
Campos, Dulce
McMurray, Rob
Villanueva, Vicente
Funding for this research was provided by:
Eisai Ltd
Text and Data Mining valid from 2019-05-16
Version of Record valid from 2019-05-16
Article History
Received: 29 March 2019
First Online: 16 May 2019